M B Plotnikov Selected Research

M B Plotnikov Research Topics

Disease

9	Brain Ischemia (Cerebral Ischemia) 12/2019 - 10/2001
5	Myocardial Ischemia (Ischemic Heart Diseases) 05/2022 - 01/2003
4	Myocardial Infarction 05/2022 - 01/2003
4	Hypertension (High Blood Pressure) 05/2017 - 03/2000
4	Ischemia 07/2016 - 10/2001
3	Experimental Diabetes Mellitus 09/2010 - 12/2007
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2019 - 02/2015
2	Inflammation (Inflammations) 03/2018 - 04/2003
2	Transient Ischemic Attack 07/2016 - 01/2009
2	Edema (Dropsy) 11/2011 - 05/2003
2	Hepatitis 01/2011 - 08/2010
2	Cardiac Arrhythmias (Arrythmia) 07/2007 - 06/2007
2	Crush Syndrome 05/2004 - 10/2001
2	Brain Diseases (Brain Disorder) 01/2004 - 01/2004
2	Headache (Headaches) 01/2004 - 01/2004
1	Ventricular Remodeling 05/2022
1	Aneurysm (Aneurysms) 05/2022
1	Male Infertility (Male Sterility) 11/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Hyperplasia 02/2015
1	Venous Insufficiency 11/2011
1	Ganglion Cysts (Ganglion) 09/2010
1	Diabetes Mellitus 09/2010
1	Hypertrophy 02/2009
1	Thrombosis (Thrombus) 03/2008
1	Coronary Occlusion 07/2007
1	Brain Edema (Cerebral Edema) 05/2007
1	Hemorrhage 09/2006
1	Stroke (Strokes) 09/2006
1	Wounds and Injuries (Trauma) 11/2005
1	Body Weight (Weight, Body) 07/2005
1	Vertigo (Positional Vertigo) 01/2004
1	Sclerosis 01/2004
1	Atherosclerosis 01/2004
1	Arteriosclerosis 01/2004
1	Macular Degeneration (Age-Related Maculopathy) 05/2003
1	Scotoma (Scintillating Scotoma) 05/2003
1	Hypovolemia 10/2001
1	Neoplasms (Cancer) 01/2001

Drug/Important Bio-Agent (IBA)

9	AntioxidantsIBA 09/2019 - 01/2004
7	ascovertinIBA 02/2009 - 10/2001
6	taxifolinIBA 09/2019 - 11/2011
5	4-hydroxyphenylethanolIBA 05/2022 - 06/2007
4	Oxygen (Dioxygen)IBA 06/2014 - 10/2001
4	Phenol (Carbolic Acid)FDA Link 06/2014 - 03/2008
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2007 - 01/2003
3	Ethylene Oxide (Oxirane)IBA 09/2006 - 01/2003
2	Sulpiride (neogama)IBA 09/2019 - 02/2015
2	Neuroprotective AgentsIBA 11/2018 - 01/2009
2	salicylhydroxamic acid (SHAM)IBA 07/2016 - 06/2014
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2011 - 08/2010
2	Fibrinogen (Factor I)FDA Link 11/2010 - 03/2000
2	4-methyl-2,6-diisobornylphenolIBA 09/2010 - 01/2009
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2008 - 06/2006
2	LipidsIBA 07/2008 - 06/2006
2	SolutionsIBA 05/2007 - 05/2003
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2003 - 01/2003
2	diquertinIBA 03/2003 - 01/2003
1	Methimazole (Thiamazole)FDA LinkGeneric 09/2019
1	ethylmethylhydroxypyridine succinateIBA 10/2018
1	polyglucosanIBA 10/2018
1	LignansIBA 01/2017
1	IsoflavonesIBA 01/2017
1	Phytoestrogens (Phytoestrogen)IBA 01/2017
1	Fluoxetine (Prozac)FDA LinkGeneric 07/2016
1	Thioctic Acid (Lipoic Acid)IBA 11/2011
1	thiophaneIBA 01/2011
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2011
1	Pyruvic Acid (Pyruvate)IBA 01/2011
1	Streptozocin (Streptozotocin)FDA Link 09/2010
1	PhenolsIBA 01/2009
1	PhosphatidylserinesIBA 07/2008
1	SphingomyelinsIBA 07/2008
1	LysophospholipidsIBA 07/2008
1	Therapeutic UsesIBA 07/2007
1	Ecdysterone (20 Hydroxyecdysone)IBA 07/2005
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 03/2005
1	Pharmaceutical PreparationsIBA 01/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2001
1	SuspensionsIBA 01/2001

Therapy/Procedure

5	Therapeutics 09/2019 - 01/2003
2	Intravenous Administration 01/2010 - 05/2003
1	Lasers (Laser) 05/2017
1	Injections 02/2015
1	Intravenous Injections 05/2007